Sign Up to like & get
recommendations!
0
Published in 2020 at "Current Cardiology Reports"
DOI: 10.1007/s11886-020-01397-9
Abstract: To determine if subsidizing the cost of a food-based intervention for managing hyperlipidemia could be cost-effective under commercial insurance and/or Medicare coverage scenarios. A large number of patients eligible for pharmaceutical treatment of hyperlipidemia either…
read more here.
Keywords:
intervention;
cost implications;
cholesterol;
healthcare cost ... See more keywords